Literature DB >> 4862704

Chlorpromazine and the untreated chronic schizophrenic: a long-term trial.

F J Letemendia, A D Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4862704     DOI： 10.1192/bjp.113.502.950

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  7 in total

1.  Assessment of drugs in schizophrenia.

Authors:  J P Leff
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 2.  Assessment of anti-psychotic drugs.

Authors:  A V Mackay
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

Review 4.  The ageing brain, neuroleptic drugs and the enigma of schizophrenia.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

5.  Orientation failures in medicine and psychiatry: discussion paper.

Authors:  G E Berrios
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 5.344

6.  A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.

Authors:  D J King; M Blomqvist; S J Cooper; M M Doherty; M J Mitchell; R C Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 7.  Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials.

Authors:  Clive Elliott Adams; John Rathbone; Ben Thornley; Mike Clarke; Jo Borrill; Kristian Wahlbeck; A George Awad
Journal:  BMC Med       Date:  2005-10-17       Impact factor: 8.775
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.